170 related articles for article (PubMed ID: 25587131)
21. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
22. In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies.
Bannas P; Well L; Lenz A; Rissiek B; Haag F; Schmid J; Hochgräfe K; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2014; 9(2):135-42. PubMed ID: 24523058
[TBL] [Abstract][Full Text] [Related]
23. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
24. Depletion of mouse alpha beta T cell antigen receptor bearing lymphocytes by neonatal monoclonal antibody treatment.
Mixter PF; Sydora BC; Hershberg RM; Kronenberg M
J Immunol; 1991 Dec; 147(12):4109-17. PubMed ID: 1836478
[TBL] [Abstract][Full Text] [Related]
25. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
26. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
Iwata M; Katamura K; Kubo RT; Ishizaka K
J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes.
Ferrini S; Prigione I; Bottino C; Ciccone E; Tambussi G; Mammoliti S; Moretta L; Moretta A
Eur J Immunol; 1989 Jan; 19(1):57-61. PubMed ID: 2784109
[TBL] [Abstract][Full Text] [Related]
28. Association of human lymph node homing receptor (Leu 8) with the TCR/CD3 complex.
Murakawa Y; Minami Y; Strober W; James SP
J Immunol; 1992 Mar; 148(6):1771-6. PubMed ID: 1371790
[TBL] [Abstract][Full Text] [Related]
29. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
Li F; Jiang S; Zu Y; Lee DY; Li Z
J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
[TBL] [Abstract][Full Text] [Related]
30. Cre/lox-assisted non-invasive in vivo tracking of specific cell populations by positron emission tomography.
Thunemann M; Schörg BF; Feil S; Lin Y; Voelkl J; Golla M; Vachaviolos A; Kohlhofer U; Quintanilla-Martinez L; Olbrich M; Ehrlichmann W; Reischl G; Griessinger CM; Langer HF; Gawaz M; Lang F; Schäfers M; Kneilling M; Pichler BJ; Feil R
Nat Commun; 2017 Sep; 8(1):444. PubMed ID: 28874662
[TBL] [Abstract][Full Text] [Related]
31. Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64.
Bhatnagar P; Li Z; Choi Y; Guo J; Li F; Lee DY; Figliola M; Huls H; Lee DA; Zal T; Li KC; Cooper LJ
Integr Biol (Camb); 2013 Jan; 5(1):231-8. PubMed ID: 23034721
[TBL] [Abstract][Full Text] [Related]
32. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
33. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
[TBL] [Abstract][Full Text] [Related]
34. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.
Cole BC; Kartchner DR; Wells DJ
J Immunol; 1990 Jan; 144(2):425-31. PubMed ID: 2136890
[TBL] [Abstract][Full Text] [Related]
36. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
37. A novel mechanism of CD4 lymphocyte depletion involves effects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors.
Wang L; Chen JJ; Gelman BB; Konig R; Cloyd MW
J Immunol; 1999 Jan; 162(1):268-76. PubMed ID: 9886395
[TBL] [Abstract][Full Text] [Related]
38. Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody.
Brenner MB; McLean J; Scheft H; Warnke RA; Jones N; Strominger JL
J Immunol; 1987 Mar; 138(5):1502-9. PubMed ID: 3492555
[TBL] [Abstract][Full Text] [Related]
39. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
